The Dish’s Weekly Biotechnology News Wrap Up – January 23, 2015
This week’s biotechnology news headlines include, ebola vaccine news, biotech investment on the rise, Obama proposes support for personalized cures, Disneyland measles case, Regenxbio pursues clinical trials, and Penn State Genomic Research Collaboration.
Cell Culture Events
February
Cell Line Development and Engineering – February 9-12, 2014, Dublin Ireland
http://www.informa-ls.com/event/Cellline
7th Annual Global Biomanufacturing Summit – February 18-20, 2015, Orange County, CA
With the affordable care act and added FDA pressure on companies to cut costs to the end user it has become imperative that the biological manufacturing industry optimizes and streamlines its processes in order to maintain profit margins and stay competitive.
The 7th Annual Global Biological Manufacturing Summit 2015 has been designed to enhance collaboration, discussion and networking amongst the Biological Manufacturing community.
The 2015 will programme will feature three dedicated streams, each tackling the latest challenges for the industry: Manufacturing, Supply chain, Quality and Regulation. Each stream will feature the most esteemed companies in their fields, including UCB, GSK, MEDIMMUNE GENENTECH, M W GROUP, KINAXIS.
Visit http://biomansummit.com/ for more information.
Book now via The Cell Culture Dish and save 15%
Cell Culture World Congress – February 23-25, 2015 –Munich Germany
The region’s premier congress for the bioprocess industry. Where all major existing and emerging players obtain practical and technical outcomes to Bioprocessing and Biomanufacturing. Cell Culture World Congress is THE networking forum where pharma, biotech, academia and associated vendor stakeholders wanting to progress within the Cell Culture and Biomanufacturing market meet, debate and partner with those already strategically positioned.
Downstream Processing World Congress – February 24-25, 2015 – Munich Germany
Technology and process optimization for pharma, biotech and CMOs. Co-located with Cell Culture World Congress, the event is THE genuine meeting place for bioprocess scientists to meet, source new technologies and share best practice.
Headlines
“J&J Ebola vaccine gets 100 million euros to speed development,” Reuters
“Johnson and Johnson said on Friday that newly formed groups supporting work on its experimental Ebola vaccine would receive 100 million euros ($115 million) from Europe’s Innovative Medicines Initiative to speed development.”
If you like this story, please see our blog titled “The Benefits of Implementing Bioprocess Monitoring and Quality by Design in Process Development”
“Riding High, Biotech Firms Remain Wary,” The New York Times
“The biotechnology industry tends to be overshadowed by the razzle-dazzle of high-tech companies like Apple, Facebook and Google, particularly in the Bay Area.”
If you like this story, please see our blog titled “Raw Material Sourcing for Cell Culture Media – Important Considerations“
“Obama Proposes U.S. Spending to Research Personalized Cures,” Bloomberg Businessweek
“President Barack Obama will urge Congress to spend U.S. taxpayers’ money for research in “precision medicine,” a burgeoning field of care in which treatments are tailored to an individual patient.”
If you like this story, please see our blog titled “2014’s Top Ten Cell Culture Dish Ask the Expert Sessions”
“Penn State Establishes Genomic Research Collaboration with Geisinger,” Genetic Engineering News
“Marylyn Ritchie, Ph.D., will lead a new collaboration between the Penn State and Geisinger Research to connect the genome data of 100,000 anonymous patients with their medical histories. The initiative aims to identify the genetic and environmental basis of human disease.”
If you like this story, please see our blog titled “Biologics Development: How do you Solve a Problem Like Data Management?”
“Biotech firm Regenxbio clinches $30M from investors as it plans to pursue clinical trials,” The Washington Post
“A District biotechnology company that uses Gene Therapy to treat diseases of the central nervous system has raised $30 million from investors to usher its drugs through clinical trials, executives said Wednesday.”
If you like this story, please see our blog titled “Stromal Cell Isolation from Adipose Tissue”
“Measles Cases Linked to Disneyland Rise, and Debate Over Vaccinations Intensifies,” The New York Times
“A measles outbreak that began at Disneyland is spreading across California and beyond, prompting health officials to move aggressively to contain it — including by barring unvaccinated students from going to school in Orange County. The outbreak has increased concerns that a longstanding movement against childhood vaccinations has created a surge in a disease that was declared eliminated in the United States in 2000.”
If you like this story, please see our blog titled “Where’s the Beef!?”
“After rocky flu season, vaccinemakers may want to follow Novartis’ lead,” Fierce Vaccines
“Heading into this year’s flu season, vaccinemakers were hoping to follow up the top-line success they scored last year with quadrivalent rollouts. But with this year’s vaccines registering a paltry 23% effectiveness rate this season thanks to a mutated strain, it might be time to make some changes.”
If you like this story, please see our blog titled “The Top 20 Cell Culture Blogs of 2014”